Kyle W. Becker
Impact in
- Immunology top 2%
- Immunotherapy and Immune Responses
- interferon and immune responses
- Immune cells in cancer
- Immune Response and Inflammation
- Molecular Medicine top 5%
Papers in
- Immunology 13
- Immunotherapy and Immune Responses 8
- interferon and immune responses 7
- Immune Response and Inflammation 5
-
- RNA Interference and Gene Delivery 4
- vaccines and immunoinformatics approaches 3
- Co-authors
- John T. Wilson (12 shared papers)Eric P. Skaar (5 shared papers)Daniel Shae (6 shared papers)Plamen P. Christov (5 shared papers)Sema Sevimli (3 shared papers)Justin M. Balko (2 shared papers)Abigail K. R. Lytton‐Jean (1 shared paper)Dong Soo Yun (1 shared paper)
- Journals
- ACS Nano (4 papers)Infection and Immunity (3 papers)Journal of Controlled Release (2 papers)Advanced Healthcare Materials (1 paper)Biomaterials (1 paper)
- Partner nations
- United StatesChina
In The Last Decade
Kyle W. Becker
17 papers receiving 1.6k citations
Kyle W. Becker's Hit Papers
Peers
Comparison fields: 5 of 92
- Immunology 965
- Molecular Medicine 117
- Endocrinology 70
- Infectious Diseases 236
- Biomaterials 143
Countries citing papers authored by Kyle W. Becker
This map shows the geographic impact of Kyle W. Becker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle W. Becker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle W. Becker more than expected).
Fields of papers citing papers by Kyle W. Becker
This network shows the impact of papers produced by Kyle W. Becker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle W. Becker. The network helps show where Kyle W. Becker may publish in the future.
Co-authors
The 25 scholars most cited alongside Kyle W. Becker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy Hit paper breakdown → | 2019 | 572 |
| 2 | 2014 | 192 | |
| 3 | 2020 | 138 | |
| 4 | 2019 | 117 | |
| 5 | 2020 | 97 | |
| 6 | 2018 | 79 | |
| 7 | A Cancer Nanovaccine for Co-Delivery of Peptide Neoantigens and Optimized Combinations of STING and TLR4 Agonists Hit paper breakdown → | 2024 | 79 |
| 8 | 2012 | 64 | |
| 9 | 2018 | 54 | |
| 10 | 2013 | 45 | |
| 11 | 2020 | 29 | |
| 12 | 2022 | 26 | |
| 13 | 2019 | 25 | |
| 14 | 2017 | 24 | |
| 15 | 2020 | 17 | |
| 16 | 2024 | 15 | |
| 17 | 2013 | 3 |
About Kyle W. Becker
Kyle W. Becker is a scholar working on Immunology, Molecular Biology, Oncology, Molecular Medicine and Endocrinology, having authored 17 papers that have together received 1.6k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (8 papers), interferon and immune responses (7 papers), Immune Response and Inflammation (5 papers), RNA Interference and Gene Delivery (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), vaccines and immunoinformatics approaches (3 papers), Antibiotic Resistance in Bacteria (3 papers) and Vibrio bacteria research studies (2 papers). The work is most often cited by research in Immunology (965 citations), Molecular Medicine (117 citations), Endocrinology (70 citations), Infectious Diseases (236 citations) and Biomaterials (143 citations). Kyle W. Becker has collaborated with scholars based in United States and China. Frequent co-authors include John T. Wilson, Eric P. Skaar, Daniel Shae, Plamen P. Christov, Sema Sevimli, Justin M. Balko, Abigail K. R. Lytton‐Jean, Dong Soo Yun, Mark C. Kelley and Douglas B. Johnson. Their work appears in journals such as ACS Nano, Infection and Immunity, Journal of Controlled Release, Advanced Healthcare Materials and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.